Comparing Treatment Results in Adults Switched to Generic ADHD Medication

Results of a recently published study, “A randomized, double-blind, cross-over, phase IV trial of oros-methylphenidate (CONCERTA®) and generic novo-methylphenidate ER-C (NOVO-generic)” confirms concerns expressed to CADDAC over the past number of years by adults with ADHD, parents of children with ADHD and physicians treating patients with ADHD who have been switched to a generic medication….

New Approaches in Researching Neurodevelopmental Disorders

Some researchers around the world have been thinking about a different way to think about mental and neurological disorders. They have found that current diagnostic categories may not align with new genetic and neuroscience findings. A unique Ontario project, the province of Ontario Neurodevelopmental Disorders (POND) Network is studying multiple disorders at the same time…